Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

被引:10
|
作者
Kasemsap, Narongrit [1 ,2 ]
Vorasoot, Nisa [1 ,2 ]
Kongbunkiat, Kannikar [1 ,2 ]
Peansukwech, Udomlack [1 ]
Tiamkao, Somsak [1 ,2 ]
Sawanyawisuth, Kittisak [1 ,2 ,3 ,4 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Med, 123 Mitraparp Highway, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, North Eastern Stroke Res Grp, Khon Kaen, Thailand
[3] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand
[4] Khon Kaen Univ, Internal Med Res Grp, Khon Kaen, Thailand
来源
关键词
acute ischemic stroke; length of stay; thrombolysis; TISSUE-PLASMINOGEN ACTIVATOR; OF-STAY; ATRIAL-FIBRILLATION; MEDICAL COMPLICATIONS; NATIONAL DATA; OUTCOMES; MORTALITY; NETHERLANDS; PREDICTOR; PNEUMONIA;
D O I
10.2147/NDT.S151836
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There are limited data available on factors associated with length of stay (LOS) in cases of acute ischemic stroke according to Poisson analysis, which is more appropriate than other methods. Materials and methods: We retrospectively reviewed medical summary charts of patients with acute ischemic stroke in 30 hospitals across northeast Thailand, with the main outcome as LOS. Poisson regression was used to examine factors associated with LOS. Results: We included 898 patients in the analysis; 460 (51.2%) were male. The median age (interquartile; IQR) was 58 (67-75) years and the median LOS was 5 (4-7) days. The median National Institute of Health Stroke Scale (NIHSS [IQR]) was 8 (4-13). Results of the analysis showed that, after controlling for age, stroke severity, atrial fibrillation, and thrombolytic use, significant variables associated with LOS were moderate stroke (incidence rate ratio [IRR] 95% confidence interval [CI] = 1.15 [range 1.01-1.30], P = 0.040), severe stroke (IRR [95% CI] = 1.27 [1.09-1.47], P = 0.002), thrombolytic use (IRR [95% CI] = 0.68 [0.60-0.76], P > 0.001), and atrial fibrillation (IRR [95% CI] = 1.15 [1.02-1.30], P = 0.023). After adjusting for complications, thrombolytic use remained significantly associated with decreased LOS (IRR [95% CI] = 0.74 [0.67-0.83], P = 0.001). Other significant factors were atrial fibrillation (IRR [95% CI] = 1.14 [1.02-1.28], P = 0.018), pneumonia (IRR [95% CI] = 1.48 [1.30-1.68], P < 0.001), and urinary tract infection (IRR [95% CI] = 1.41 [1.14-1.74], P = 0.001). Conclusion: According to Poisson analysis, intravenous thrombolysis, atrial fibrillation, pneumonia, and urinary tract infection are associated with LOS in cases of acute ischemic stroke, regardless of age, stroke severity, comorbidities, or complications.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [21] The Impact Factors on the Cost and Length of Stay among Acute Ischemic Stroke
    Huang, Ying-Chih
    Hu, Chaur-Jong
    Lee, Tsong-Hai
    Yang, Jen-Tsung
    Weng, Hsu-Huei
    Lin, Leng Chieh
    Lai, Shiao-Lin
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (07): : E152 - E158
  • [22] Determinants of Prolonged Length of Hospital Stay in Patients with Severe Acute Ischemic Stroke
    Lin, Kuan-Hung
    Lin, Huey-Juan
    Yeh, Poh-Shiow
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [23] Impact of Thrombus Shift by Intravenous Thrombolysis on Endovascular Therapy for Acute Ischemic Stroke
    Sugiura, Y.
    Yamagami, H.
    Hayakawa, M.
    Ishii, D. Daizo
    Morita, K.
    Satow, T.
    Takahashi, J. C.
    Toyoda, K.
    Nagatsuka, K.
    CEREBROVASCULAR DISEASES, 2014, 37 : 249 - 249
  • [24] SAFETY OF INTRAVENOUS THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE IN ELDERLY
    Naheed, D.
    Kumar, A. S.
    Khurana, D.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 92 - 92
  • [25] Intravenous Thrombolysis for Acute Ischemic Stroke Time Is Prime
    Ingall, Timothy J.
    STROKE, 2009, 40 (06) : 2264 - 2265
  • [26] The Belgian experience with intravenous thrombolysis for acute ischemic stroke
    Vanacker, P.
    Thijs, V.
    Peeters, A.
    Bruneel, B.
    Laloux, P.
    Druwe, P.
    De Deyn, P.
    Ahmed, N.
    Wahlgren, N.
    Vanhooren, G.
    ACTA NEUROLOGICA BELGICA, 2010, 110 (02) : 157 - 162
  • [27] Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia
    Mowla, Ashkan
    Kamal, Hans
    Lail, Navdeep
    Vaughn, Caila
    Mehla, Sandhya
    Deline, Christopher
    Ching, Marilou
    Crumlish, Annemarie
    Sawyer, Robert
    NEUROLOGY, 2017, 88
  • [28] Intravenous Thrombolysis For Acute Ischemic Stroke in Fabry Disease
    Kargiotis, Odysseas
    Psychogios, Klearchos
    Safouris, Apostolos
    Kalyvas, Pericles
    Magoufis, Georgios
    Stamboulis, Eleftherios
    Tsivgoulis, Georgios
    NEUROLOGIST, 2019, 24 (05) : 146 - 149
  • [29] Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
    Nam, Ki-Woong
    Kim, Chi Kyung
    Kim, Tae Jung
    An, Sang Joon
    Oh, Kyungmi
    Ko, Sang-Bae
    Yoon, Byung-Woo
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [30] Combined intraarterial/intravenous thrombolysis for acute ischemic stroke
    Keris, V
    Rudnicka, S
    Vorona, V
    Enina, G
    Tilgale, B
    Friebergs, J
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2001, 22 (02) : 352 - 358